Coya Therapeutics Inc. logo

Coya Therapeutics Inc.

COYA | NASDAQ
Chart Builder DCF Calculator
$5.21
+$0.26 (+5.25%)
Sep 22, 2026, 10:50 AM ET · Market open
TTM
Period Ending
Q2 2026
Jun 29, 2026
Q1 2026
Mar 30, 2026
Q4 2025
Dec 30, 2025
Q3 2025
Sep 29, 2025
Q2 2025
Jun 29, 2025
Q1 2025
Mar 30, 2025
Q4 2024
Dec 30, 2024
Q3 2024
Sep 29, 2024
Q2 2024
Jun 29, 2024
Q1 2024
Mar 30, 2024
Q4 2023
Dec 30, 2023
Q3 2023
Sep 29, 2023
Q2 2023
Jun 29, 2023
Q1 2023
Mar 30, 2023
Q4 2022
Dec 30, 2022
Q3 2022
Sep 29, 2022
Q2 2022
Jun 29, 2022
Q1 2022
Mar 30, 2022
Q4 2021
Dec 30, 2021
Q3 2021
Sep 29, 2021
Q2 2021
Jun 29, 2021
Q1 2021
Mar 30, 2021
Revenue
8.02M 7.94M 7.95M 3.99M 423.45K 3.69M 3.55M 9.55M 9.55M 6.13M 6M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
6.84K 13.68K 5.23M 7.17M 9.38M 13.94M 11.87M 11.54M 10.91M 7.41M 5.5M 8.3M 6.71M 5.64M 4.41M n/a n/a n/a n/a n/a n/a n/a
Gross Profit
8.01M 7.93M 2.72M -3.18M -8.96M -10.26M -8.31M -1.98M -1.35M -1.28M 500.68K -8.3M -6.71M -5.64M -4.41M n/a n/a n/a n/a n/a n/a n/a
Operating Income
-22.63M -22M -22.04M -20.09M -22.62M -19.44M -17.25M -11.35M -10.47M -10.49M -7.9M -11.72M -10.82M -11.01M -9.81M -9.41M -8.08M -5.6M -4.87M -3.27M -1.94M -970.5K
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-21.67M -21.12M -21.22M -19.15M -21.06M -17.86M -15.6M -9.98M -9.38M -9.58M -7.26M -12.36M -12.96M -13.28M -12.24M -10.77M -8.08M -5.63M -4.89M -3.26M -1.93M -966.07K
Net Income
-21.67M -21.13M -21.23M -18.43M -20.34M -17.14M -14.88M -10.7M -10.1M -10.3M -7.99M -12.36M -12.96M -13.28M -12.24M -10.77M -8.08M -5.63M -4.89M -3.26M -1.93M -966.07K
Selling & General & Admin
11.86M 2.92B 2.92B 2.92B 2.92B 9.16M 8.89M 9.13M 8.87M 8.61M 7.83M 6.35M 5.63M 5.79M 4.85M 4.68M 3.99M 2.51M 2.31M 1.58M 1.04M 518.3K
Research & Development
18.77M 3.68B 3.68B 3.67B 3.67B 13.94M 11.89M 11.76M 11.12M 7.98M 6.04M 5.34M 5.16M 5.19M 4.94M 4.7M 4.07M 3.07M 2.54M 1.69M 900.97K 450.48K
Other Expenses
14.11K -6.56B -6.57B -6.57B -6.57B -13.91M -11.84M -11.51M -10.88M -7.38M -5.47M -8.28M -6.68M -5.61M -4.39M 30.71K 20.78K 18.46K 16.13K 5.95K 3.42K 1.71K
Operating Expenses
30.65M 29.93M 24.76M 16.91M 13.66M 9.19M 8.94M 9.37M 9.12M 9.21M 8.4M 3.42M 4.11M 5.37M 5.4M 9.41M 8.08M 5.6M 4.87M 3.27M 1.94M 970.5K
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
30.65M 29.94M 29.98M 24.08M 23.05M 23.13M 20.8M 20.91M 20.02M 16.62M 13.91M 11.72M 10.82M 11.01M 9.81M 9.41M 8.08M 5.6M 4.87M 3.27M 1.94M 970.5K
Income Tax Expense
3.09K 3.09K 3.09K -720.29K -720.29K -720.29K -720.29K 723.85K 723.85K 723.85K 723.85K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
23.46M 22.64M 16.73M 16.73M 16.72M 16.72M 16.36M 15.22M 14.92M 14.46M 10.16M 9.95M 9.95M 9.95M 9.95M 9.68M 6.6M 6.6M 6.6M 9.68M 2.59M 2.59M
Shares Outstanding (Diluted)
23.46M 22.64M 16.73M 16.73M 16.72M 16.72M 16.36M 15.22M 14.92M 14.46M 10.16M 9.95M 9.95M 9.95M 9.95M 9.68M 6.6M 6.6M 6.6M 9.68M 2.59M 2.59M
EPS (Basic)
-1.07 -1.15 -1.27 -1.11 -1.24 -1.07 -0.98 -0.68 -0.76 -0.88 -0.79 -1.33 -1.41 -1.62 -1.62 -1.45 -1.17 -1.02 -1.13 -0.88 -0.74 -0.37
EPS (Diluted)
-1.07 -1.15 -1.27 -1.11 -1.24 -1.07 -0.98 -0.68 -0.76 -0.88 -0.79 -1.33 -1.41 -1.62 -1.62 -1.45 -1.17 -1.02 -1.13 -0.88 -0.74 -0.37
EBITDA
-22.07M -21.52M -21.2M -19.13M -21.03M -17.83M -15.98M -10.34M -9.74M -9.75M -7.03M -10.65M -9.75M -10.26M -9.23M -9.24M -8.06M -5.61M -4.88M -3.26M -1.93M -968.79K
EBIT
-22.09M -21.55M -21.22M -19.15M -21.06M -17.86M -16.01M -10.36M -9.76M -9.78M -7.05M -10.68M -9.78M -10.29M -9.26M -9.27M -8.08M -5.63M -4.9M -3.27M -1.94M -970.5K
Depreciation & Amortization
19.3K 23.33K 27.36K 27.36K 27.36K 27.36K 27.36K 27.36K 27.36K 27.36K 27.36K 27.36K 32.98K 30.17K 27.36K 30.71K 20.78K 18.46K 16.13K 5.95K 3.42K 1.71K

© 2026 bestshares.com. All rights reserved.